423014 — New York, New York

423014 is a clinical research site located in New York, New York, United States 10017.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

423014 has participated in 1 clinical trials.

Therapeutic areas: MAC Lung Disease, Treatment Refractory MAC Lung Disease.

Sponsors: AN2 Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 423014?

423014 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 423014 conducted?

423014 has 1 clinical trials on record. Their work covers MAC Lung Disease, Treatment Refractory MAC Lung Disease.

Is 423014 accredited by Crixeo Health?

423014 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 423014?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.